… β-lactam combined with aminoglycoside or fluoroquinolone with that of β-lactam monotherapy
… aeruginosa infections receiving treatment with β-lactams alone or in combination with an …

… -lactams (BLs) and fluoroquinolones (FQs), given either together in combination therapy or
alone in monotherapy. … FQ agents as active, definitive monotherapy in PA infections in adults. …

… Hence, it should be noted that no study had evaluated outcomes following β-lactam-macrolide
combination therapy versus fluoroquinolone monotherapy for PSI class V VA patients …

… a combination of beta-lactams and fluoroquinolones or beta-lactam monotherapy. We enrolled
… that combination therapy with beta-lactams and fluoroquinolones was associated with a …

… respiratory fluoroquinolone monotherapy and β-lactam with … of respiratory fluoroquinolone
monotherapy and β-lactam with … to the respiratory fluoroquinolone in overall mortality (RR 0.82…

… with other antimicrobials has been considered equivalent to beta-lactam monotherapy for …
-lactam monotherapy and combination therapy with an aminoglycoside or a quinolone were …

Introduction Guidelines recommend respiratory fluoroquinolone monotherapy or β-lactam
plus macrolide combination therapy as first-line options for hospitalized adults with mild to …

… : quinolone or macrolide monotherapy versus their … monotherapy with a respiratory
fluoroquinolone. The ecological implications of selecting fluoroquinolone or β-lactam monotherapy …

… Several studies have demonstrated that monotherapy with β‑lactam is associated with
worse outcomes, including increased mortality and increased length of stay [11–13, 26, 27]. …

… -lactams (BLs) and fluoroquinolones (FQs), given either together in combination therapy or
alone in monotherapy. … FQ agents as active, definitive monotherapy in PA infections in adults. …